Author: Julie Simpson

CSO is pleased to announce the outcome of the second funding round for the Scottish Seedcorn Fund for Neurological Research.

Jointly funded by the RS Macdonald Charitable Trust and the Chief Scientist Office, the scheme provides up to £15,000 of funding per application for small innovative projects investigating the cause, prevention, treatment and/or management of neurodegenerative or neurodevelopmental disorders. To encourage the development of collaborative networks, all projects need to involve at least 2 academic centres.

Following an independent expert review process, 9 projects have been awarded funding. The portfolio of research includes basic science, clinical and qualitative approaches aimed at better understanding conditions including Parkinson’s, Motor Neurone Disease and Alzheimer’s Disease.

The list of funded projects is available here

The Scottish Seedcorn Fund for Neurological Research is administered by the University of St Andrews – both CSO and the RS Macdonald Charitable Trust would like acknowledge the work carried out by the University in this regard.

The Chief Scientist Office is looking to appoint a National Research Network Clinical Lead for Metabolic and Endocrine Disorders 

The remit of this role is to ensure the effective delivery of research projects in the NHS Research Scotland (NRS) Metabolic and Endocrine portfolio, including increasing the number of patients enrolled into trials. The post holder will be expected to work closely with the NRS Portfolio Performance Manager, together with established groups, individual clinicians, NRS Research & Development Directors and lay representatives to promote, deliver and develop Research, Development and Innovation (RD&I) activity in the area, and with CSO on wider NRS strategic initiatives.

The post holder will be an established clinician resident and working in Scotland, and must be able to demonstrate a proven track record in clinical research activity within one or more areas of Metabolic and Endocrine disorders.

Hours: 0.1FTE/ 1PA per week

Salary: Pro-rata within the post holder’s pay scale

Length: 3 years in the first instance, with the possibility to extend

NRS Metabolic and Endocrine Disorders Job Description

Applications, comprising a succinct CV (3-page maximum) and cover letter should be submitted to David Hood by the closing date of 5pm on Friday 15^th October 2021.

Interviews will be held remotely in November 2021.

Please contact Alan McNair if you would like to discuss further prior to application